Freestone Grove Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.3M Buy
1,311,722
+649,865
+98% +$24.1M 0.33% 80
2026
Q1
$26.5M Buy
+661,857
New +$31.3M 0.19% 177
2025
Q2
Sell
-251,052
Closed -$10.1M 820
2025
Q1
$10.1M Sell
251,052
-263,853
-51% -$11.1M 0.1% 228
2024
Q4
$23.6M Buy
+514,905
New +$23.1M 0.29% 117

Other funds holding QGEN

Freestone Grove Partners's QGEN Position: Q2 2026 in Review

Freestone Grove Partners increased its Qiagen (QGEN) stake by 98% in Q2 2026, buying an estimated $24.1M and bringing the position to 1,311,722 shares worth $51.3M. The position accounts for 0.33% of the portfolio, ranked #80.

Freestone Grove Partners first reported a position in QGEN in Q4 2024 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Freestone Grove Partners held 1,311,722 shares of Qiagen worth $51.3M as of Q2 2026.
  • Freestone Grove Partners bought 649,865 Qiagen shares in Q2 2026, an estimated $24.1M.
  • Qiagen made up 0.33% of Freestone Grove Partners's portfolio in Q2 2026, its #80 holding.
  • Freestone Grove Partners first reported a position in Qiagen in Q4 2024 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.